Brief: Edwards Says Co Will Not Acquire Jenavalve
09/01/2026 23:51
Jan 9 (Reuters) - Edwards Lifesciences Corp EW.N: EDWARDS COMMENTS ON JENAVALVE ACQUISITION EDWARDS LIFESCIENCES CORP - REVISES 2026 EPS GUIDANCE TO $2.90-$3.05 EDWARDS LIFESCIENCES CORP - FTC BLOCKS EDWARDS' ACQUISITION OF JENAVALVE EDWARDS LIFESCIENCES CORP: EDWARDS WILL NOT ACQUIRE JENAVALVE Source text: ID:nBw8spmFxa Further company coverage: EW.N ((Reuters.briefs@thomsonreuters.com;))
Recent news on Edwards Lifesciences
See all newsFDA flags Edwards heart-valve delivery system issue after death, injury (updated)
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals